中药联合小剂量美罗华治疗成人慢性难治性免疫性血小板减少症6例

来源 :深圳中西医结合杂志 | 被引量 : 0次 | 上传用户:fei5051484
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的:探究中药联合小剂量美罗华治疗成人慢性难治性免疫性血小板减少症(ITP)的效果。方法:选取广东省中医院收治的成人慢性难治性ITP患者6例,采取中药联合小剂量美罗华进行治疗,观察治疗后的效果。结果:6例患者均完成治疗,总有效率为100%,无出血倾向,血小板较治疗前升高。2例患者发生静脉输注相关事件,经减慢滴注速度及对症处理后症状改善并坚持输注完毕;6例患者至今均无复发。结论:中药联合小剂量美罗华治疗成人慢性难治性ITP的效果较好。 Objective: To explore the effect of traditional Chinese medicine combined with low-dose rituximab in the treatment of chronic refractory immune thrombocytopenia (ITP) in adults. Methods: Six adult patients with chronic refractory ITP admitted to Guangdong Provincial Hospital of Traditional Chinese Medicine were selected and treated with traditional Chinese medicine combined with low dose of Rituximab to observe the effect after treatment. Results: All 6 patients completed the treatment, with a total effective rate of 100%, no bleeding tendency, and platelets increased compared with those before treatment. Two patients had an IV infusion-related event. The infusion rate was slowed down and symptoms were improved after symptomatic treatment and infusion was completed. No recurrence occurred in 6 patients so far. Conclusion: Chinese medicine combined with low-dose rituximab treatment of adult chronic refractory ITP better.
其他文献
在三相电压型PWM整流器传统模型预测直接功率控制(Model Predictive Direct Power Control,MPDPC)的基础上引入延时补偿控制,得到一种改进MPDPC。为了探究改进MPDPC和传统MPDPC
近年来,媒体有关产权多元化是“改革关键”、“改革核心、“根本出路”、“无法回避”等讨论多不胜数。产权多元化作为国企改制的形式,最终目的是为了增强国有经济的活力、控制
近几年人们生活水平不断提升,也导致了糖尿病的发病率不断提升,这就对糖尿病的根治提出了新的要求,因此我国的中医内科也经过积极的研究分析,发现了许多糖尿病治疗方面的新的